PROPANE-1,3-DIYLBISPHOSPHONIC ACID TETRAETHYL ESTER, 95.0%, 5g

5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 2.5g

4-Ethoxyphenylacetonitrile, 98.0%, 100g

4-(4-Morpholinopiperidin-1-yl)aniline, 95%, 250mg

(4aR,7aR)-tert-Butyl hexahydropyrrolo[3,4-b][1,4]oxazine-6(2H)-carboxylate, 97%, 100mg

Tert-butyl n-(5-amino-2,4-difluorophenyl)carbamate, 95%, 1g

Flacons à vis autonomes stériles, 1,5 ml, 1000 pièce(s)

tert-butyl 2-(5,5-dimethyl-2,4-dioxothiazolidin-3-yl)ethylcarbamate, 1g

9-Azabicyclo[3.3.1]nonan-3-one hydrochloride, 95.0%, 5g

2-(chloromethyl)-5-(oxan-4-yl)-1,3,4-oxadiazole, 95.0%, 1g

(5E)-2-mercapto-5-[4-(trifluoromethyl)benzylidene]-1,3-thiazol-4(5H)-one, 95.0%, 5g

3-Fluoro-2-methoxyisonicotinonitrile, 95.0%, 1g

(1R,3R)-METHYL 1-(BENZO[D][1,3]DIOXOL-5-YL)-2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLATE HCL, 98.0%, 100g